title: Epidemiology of inhibitor development in haemophilia A patients treated with virus-inactivated plasma-derived clotting factor concentrates.
authors.affiliation: Johann Wolfgang Goethe University Hospital, Department of Paediatrics III (Haematology and Oncology), Centre of Haemophilia and Thrombosis, Frankfurt am Main, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Kreuz
authors.forename: C
authors.initials: C
authors.lastname: Escuriola-Ettingshausen
authors.forename: I
authors.initials: I
authors.lastname: Martinez-Saguer
authors.forename: M
authors.initials: M
authors.lastname: Kaiml
authors.forename: B
authors.initials: B
authors.lastname: Kornhuber
mesh_terms: D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors* / Q000276:immunology; D002675:Child, Preschool; D005164:Factor IX / Q000037:antagonists & inhibitors / Q000276:immunology; D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000276:immunology; D006467:Hemophilia A / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D015994:Incidence; D007223:Infant; D007518:Isoantibodies / Q000009:adverse effects / Q000097:blood / Q000187:drug effects; D015995:Prevalence
chemical_list: D001779:Blood Coagulation Factors; D007518:Isoantibodies; C025667:prothrombin complex concentrates; D005169:Factor VIII; D005164:Factor IX